Universe Pharmaceuticals (UPC) Equity Ratio (2020 - 2025)

Universe Pharmaceuticals has disclosed Equity Ratio across 6 years of filings, most recently posting 0.81 for Q3 2025.

• Equity Ratio for Q3 2025 came in at 0.81, up 20.95% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.81 (up 20.95% YoY), and the FY2025 annual result was 0.81, up 20.95% from the prior year.
• Equity Ratio came in at 0.81 for Q3 2025 at Universe Pharmaceuticals, up from 0.67 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 670.35 in Q3 2023 to a low of 0.54 in Q1 2024.
• The 5-year median for Equity Ratio is 0.74 (2025), against an average of 158.5.
• Across the five-year window, Equity Ratio tumbled 100.0% in 2021 and soared 88474.92% in 2022, its largest moves.
• Universe Pharmaceuticals' Equity Ratio stood at 0.67 in 2021, then jumped by 88474.92% to 593.39 in 2022, then climbed by 12.97% to 670.35 in 2023, then sank by 99.9% to 0.67 in 2024, then climbed by 20.95% to 0.81 in 2025.
• The last three Equity Ratio figures came in at 0.81 (Q3 2025), 0.67 (Q3 2024), and 0.54 (Q1 2024), per Business Quant data.